Healthcare Value Capital’s Pfizer PFE Stock Holding History

Healthcare Value Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$3.23M	Sell	75,000 -25,000	-25%	-$1.11M	6.37%	3
2021 Q2	$3.92M	Hold	100,000	–	–	7.8%	3
2021 Q1	$3.62M	Buy	+100,000	New	+$3.55M	8.07%	2
2019 Q3	–	Sell	-52,700	Closed	-$2.17M	–	28
2019 Q2	$2.17M	Buy	+52,700	New	+$2.09M	4.06%	11
2017 Q4	–	Sell	-263,500	Closed	-$8.93M	–	15
2017 Q3	$8.93M	Hold	263,500	–	–	17.86%	2
2017 Q2	$8.4M	Hold	263,500	–	–	15.09%	1
2017 Q1	$8.55M	Hold	263,500	–	–	14.63%	2
2016 Q4	$8.12M	Buy	263,500 +79,050	+43%	+$2.41M	8.7%	3
2016 Q3	$5.93M	Hold	184,450	–	–	9.39%	3
2016 Q2	$6.16M	Hold	184,450	–	–	7.47%	4
2016 Q1	$5.19M	Buy	184,450 +26,350	+17%	+$753K	7.62%	3
2015 Q4	$4.84M	Hold	158,100	–	–	8.01%	4
2015 Q3	$4.71M	Hold	158,100	–	–	6.72%	5
2015 Q2	$5.03M	Hold	158,100	–	–	5.28%	7
2015 Q1	$5.22M	Hold	158,100	–	–	5.69%	7
2014 Q4	$4.67M	Buy	158,100 +52,700	+50%	+$1.51M	8.54%	5
2014 Q3	$2.96M	Sell	105,400 -52,700	-33%	-$1.48M	2.85%	14
2014 Q2	$4.45M	Buy	158,100 +52,700	+50%	+$1.5M	3.73%	11
2014 Q1	$3.21M	Buy	+105,400	New	+$3.14M	2.1%	19

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Healthcare Value Capital's PFE Position: Q3 2021 in Review

Healthcare Value Capital reduced its Pfizer (PFE) stake by 25% in Q3 2021, selling an estimated $1.11M and leaving 75,000 shares worth $3.23M. The position accounts for 6.37% of the portfolio, ranked #3.

Healthcare Value Capital first reported a position in PFE in Q1 2014 and has held it in 19 quarters since. The position peaked at $8.93M in Q3 2017. 2,803 funds tracked by Wall St. Rank hold PFE as of Q3 2021.

Healthcare Value Capital held 75,000 shares of Pfizer worth $3.23M as of Q3 2021.
Healthcare Value Capital sold 25,000 Pfizer shares in Q3 2021, an estimated $1.11M.
Pfizer made up 6.37% of Healthcare Value Capital's portfolio in Q3 2021, its #3 holding.
Healthcare Value Capital first reported a position in Pfizer in Q1 2014 and has held it in 19 quarters since.
Healthcare Value Capital's Pfizer position peaked at $8.93M in Q3 2017.
2,803 funds tracked by Wall St. Rank held Pfizer as of Q3 2021.

Based on Healthcare Value Capital's 13F filing for Q3 2021, filed 15 Nov 2021.